Bastion Therapeutics
Creating a future where inflammatory disorders are curable
6 employees · est. 2018 · London, United Kingdom
Egle Therapeutics
Modulating T-regulatory cells to balance immunity
45 employees · est. 2020 · Paris, France
Bastion Therapeutics is the older company (2018 vs 2020); Egle Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Bastion Therapeutics | Egle Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2020 |
| Headquarters | ||
| Headquarters | London, United Kingdom | Paris, France |
| Employees | ||
| Employees | 6 | 45 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Unknown | Grant |
| Total Funding | ||
| Total Funding | $840.00K | $49.30M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | Not tracked yet | developing breakthrough therapies designed to modulate regulatory T cells for the treatment of cancer and autoimmune diseases |
| Target Customers | ||
| Target Customers | Not tracked yet | patients with cancer and autoimmune diseases |
| Taxonomy | ||
| Taxonomy | Treg Cell Therapies, Inflammatory Disorders, Preclinical Stage, Immune Modulation, GRIT™ Platform Technology, Novel Therapies, Cell Engineering, Immune System Enhancement, Life Sciences, Therapeutic Development, Biomedical Innovation | Immunomodulation, T-regulatory Cells, Immunotherapy, Oncology, Autoimmune Diseases, Immune Suppressor, Regulatory T-cells, Paris, Emerging, Cancer Treatment, Immune System, Therapeutic Development |
| Website | ||
| Website | bastion-tx.com | egle-tx.com |
About Bastion Therapeutics
Bastion Therapeutics, founded in 2018 and headquartered in the United Kingdom, is a preclinical stage biotech company with a compelling vision: Creating a future where inflammatory disorders are curable. Focused on developing innovative Treg cell therapies, the company targets the vast unmet clinica...
About Egle Therapeutics
Egle Therapeutics is a biotechnology startup based in France, founded in 2020. The company focuses on modulating T-regulatory cells (Tregs) to balance immunity, employing a unique concept that involves starving Tregs while specifically targeting the most immunosuppressive ones. Egle Therapeutics rec...
We will tell you when either one moves
BounceWatch watches Bastion Therapeutics and Egle Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Bastion Therapeutics and Egle Therapeutics — by email.
Frequently Asked Questions
Compare Bastion Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Bastion Therapeutics on 5 Apr 2026, and Egle Therapeutics on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
